{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:25:17Z","timestamp":1781616317996,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T00:00:00Z","timestamp":1471910400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2739-6","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T16:48:08Z","timestamp":1471970888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions"],"prefix":"10.1186","volume":"16","author":[{"given":"Maximilian","family":"Linxweiler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Bochen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Schick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Wemmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Al Kadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hasenfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer-Maria","family":"Bohle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Juhasz-B\u00f6ss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich-Franz","family":"Solomayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan Ferenc","family":"Takacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,23]]},"reference":[{"key":"2739_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"2739_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1586\/14737140.2014.866041","volume":"14","author":"LM Elit","year":"2014","unstructured":"Elit LM, Hirte H. Management of advanced or recurrent cervical cancer: chemotherapy and beyond. Expert Rev Anticancer Ther. 2014;14:319\u201332.","journal-title":"Expert Rev Anticancer Ther"},{"key":"2739_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y","volume":"19","author":"K Heselmeyer","year":"1997","unstructured":"Heselmeyer K, Macville M, Schrock E, Blegen H, Hellstrom AC, Shah K, et al. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Gene Chromosomes Cancer. 1997;19:233\u201340.","journal-title":"Gene Chromosomes Cancer"},{"key":"2739_CR4","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1054\/bjoc.2000.1509","volume":"83","author":"DG Allen","year":"2000","unstructured":"Allen DG, White DJ, Hutchins AM, Scurry JP, Tabrizi SN, Garland SM, et al. Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer. 2000;83:1659\u201363.","journal-title":"Br J Cancer"},{"key":"2739_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0165-4608(99)00135-1","volume":"117","author":"M Sugita","year":"2000","unstructured":"Sugita M, Tanaka N, Davidson S, Sekiya S, Varella-Garcia M, West J, et al. Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet. 2000;117:9\u201318.","journal-title":"Cancer Genet Cytogenet"},{"key":"2739_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ygyno.2008.01.040","volume":"110","author":"NP Caraway","year":"2008","unstructured":"Caraway NP, Khanna A, Dawlett M, Guo M, Guo N, Lin E, et al. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecol Oncol. 2008;110:37\u201342.","journal-title":"Gynecol Oncol"},{"key":"2739_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1073\/pnas.93.1.479","volume":"93","author":"K Heselmeyer","year":"1996","unstructured":"Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A. 1996;93:479\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2739_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cancergencyto.2004.06.002","volume":"157","author":"FY Huang","year":"2005","unstructured":"Huang FY, Kwok YK, Lau ET, Tang MH, Ng TY, Ngan HY. Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas. Cancer Genet Cytogenet. 2005;157:42\u20138.","journal-title":"Cancer Genet Cytogenet"},{"key":"2739_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/(SICI)1098-2264(199902)24:2<144::AID-GCC7>3.0.CO;2-9","volume":"24","author":"M Kirchhoff","year":"1999","unstructured":"Kirchhoff M, Rose H, Petersen BL, Maahr J, Gerdes T, Lundsteen C, et al. Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia\/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chromosomes Cancer. 1999;24:144\u201350.","journal-title":"Genes Chromosomes Cancer"},{"key":"2739_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.lungcan.2006.12.010","volume":"56","author":"E Dehan","year":"2007","unstructured":"Dehan E, Ben-Dor A, Liao W, Lipson D, Frimer H, Rienstein S, et al. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer. 2007;56:175\u201384.","journal-title":"Lung Cancer"},{"key":"2739_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jcla.20385","volume":"24","author":"YC Chang","year":"2010","unstructured":"Chang YC, Yeh KT, Liu TC, Chang JG. Molecular cytogenetic characterization of esophageal cancer detected by comparative genomic hybridization. J Clin Lab Anal. 2010;24:167\u201374.","journal-title":"J Clin Lab Anal"},{"key":"2739_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1755-8794-2-21","volume":"2","author":"PM Haverty","year":"2009","unstructured":"Haverty PM, Hon LS, Kaminker JS, Chant J, Zhang Z. High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors. BMC Med Genomics. 2009;2:21.","journal-title":"BMC Med Genomics"},{"key":"2739_CR13","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1158\/1055-9965.EPI-09-0349","volume":"18","author":"JJ Sheu","year":"2009","unstructured":"Sheu JJ, Lee CH, Ko JY, Tsao GS, Wu CC, Fang CY, et al. Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2009;18:2709\u201316.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2739_CR14","first-page":"5325","volume":"5","author":"U Bockm\u00fchl","year":"1996","unstructured":"Bockm\u00fchl U, Schwendel A, Dietel M, Petersen I. Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res. 1996;5:5325\u20139.","journal-title":"Cancer Res"},{"key":"2739_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ajpath.2011.10.039","volume":"180","author":"M Linxweiler","year":"2012","unstructured":"Linxweiler M, Linxweiler J, Barth M, Benedix J, Jung V, Kim YJ, et al. Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer. Am J Pathol. 2012;180:473\u201383.","journal-title":"Am J Pathol"},{"key":"2739_CR16","doi-asserted-by":"publisher","first-page":"6913","DOI":"10.1158\/0008-5472.CAN-07-5084","volume":"68","author":"H Yamamoto","year":"2008","unstructured":"Yamamoto H, Shigematsu H, Nomura M, Lockwood WW, Sato M, Okumura N, et al. PIK3CA mutations and copy number gains in human lung cancers. Cancer Res. 2008;68:6913\u201321.","journal-title":"Cancer Res"},{"key":"2739_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1164\/rccm.201001-0005OC","volume":"182","author":"F McCaughan","year":"2010","unstructured":"McCaughan F, Pole JC, Bankier AT, Konfortov BA, Carroll B, Falzon M, et al. Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer. Am J Respir Crit Care Med. 2010;182:83\u201391.","journal-title":"Am J Respir Crit Care Med"},{"key":"2739_CR18","first-page":"7113","volume":"63","author":"PP Massion","year":"2003","unstructured":"Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res. 2003;63:7113\u201321.","journal-title":"Cancer Res"},{"key":"2739_CR19","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1002\/ijc.22585","volume":"120","author":"N Comtesse","year":"2007","unstructured":"Comtesse N, Keller A, Diesinger I, Bauer C, Kayser K, Huwer H, et al. Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung. Int J Cancer. 2007;120:2538\u201344.","journal-title":"Int J Cancer"},{"key":"2739_CR20","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1242\/jcs.153650","volume":"127","author":"SJ Jung","year":"2014","unstructured":"Jung SJ, Kim JE, Reithinger JH, Kim H. The Sec62-Sec63 translocon facilitates translocation of the C-terminus of membrane proteins. J Cell Sci. 2014;127:4270\u20138.","journal-title":"J Cell Sci"},{"key":"2739_CR21","doi-asserted-by":"publisher","first-page":"18058","DOI":"10.1074\/jbc.M113.473009","volume":"288","author":"JH Reithinger","year":"2013","unstructured":"Reithinger JH, Kim JE, Kim H. Sec62 protein mediates membrane insertion and orientation of moderately hydrophobic signal anchor proteins in the endoplasmic reticulum (ER). J Biol Chem. 2013;288:18058\u201367.","journal-title":"J Biol Chem"},{"key":"2739_CR22","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1091\/mbc.E12-03-0228","volume":"23","author":"AK Lakkaraju","year":"2012","unstructured":"Lakkaraju AK, Thankappan R, Mary C, Garrison JL, Taunton J, Strub K. Efficient secretion of small proteins in mammalian cells relies on Sec62-dependent posttranslational translocation. Mol Biol Cell. 2012;23:2712\u201322.","journal-title":"Mol Biol Cell"},{"key":"2739_CR23","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1002\/ijc.25580","volume":"128","author":"M Greiner","year":"2011","unstructured":"Greiner M, Kreutzer B, Jung V, Grobholz R, Hasenfus A, St\u00f6hr RF, et al. Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells. Int J Cancer. 2011;128:2284\u201395.","journal-title":"Int J Cancer"},{"key":"2739_CR24","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/1471-2407-13-574","volume":"13","author":"M Linxweiler","year":"2013","unstructured":"Linxweiler M, Schorr S, Schauble N, Jung M, Linxweiler J, Langer F, et al. Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: a clinically tested small molecule phenocopy of SEC62 gene silencing in human tumor cells. BMC Cancer. 2013;13:574.","journal-title":"BMC Cancer"},{"key":"2739_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.euprot.2014.05.004","volume":"4","author":"J Linxweiler","year":"2014","unstructured":"Linxweiler J, Kollipara L, Zahedi RP, Lampel P, Zimmermann R, Greiner M. Proteomic insights into non-small cell lung cancer: new ideas for cancer diagnosis and therapy from a functional viewpoint. EuPA Open Proteomics. 2014;4:25\u201339.","journal-title":"EuPA Open Proteomics"},{"key":"2739_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2407-12-48","volume":"12","author":"J Lopez","year":"2012","unstructured":"Lopez J, Poitevin A, Mendoza-Martinez V, Perez-Plasencia C, Garcia-Carranca A. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer. 2012;12:48.","journal-title":"BMC Cancer"},{"key":"2739_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4132\/KoreanJPathol.2012.46.4.341","volume":"46","author":"NH Myong","year":"2012","unstructured":"Myong NH. Loss of E-cadherin and acquisition of vimentin in epithelial-mesenchymal transition are noble indicators of uterine cervix cancer progression. Korean J Pathol. 2012;46:341\u20138.","journal-title":"Korean J Pathol"},{"key":"2739_CR28","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/j.1365-2559.2012.04326.x","volume":"61","author":"MH Koay","year":"2012","unstructured":"Koay MH, Crook M, Stewart CJ. Cyclin D1, E-cadherin and beta-catenin expression in FIGO Stage IA cervical squamous carcinoma: diagnostic value and evidence for epithelial-mesenchymal transition. Histopathology. 2012;61:1125\u201333.","journal-title":"Histopathology"},{"key":"2739_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/00313020701329914","volume":"39","author":"M Guarino","year":"2007","unstructured":"Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 2007;39:305\u201318.","journal-title":"Pathology"},{"key":"2739_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/0022034512467352","volume":"92","author":"CS Scanlon","year":"2013","unstructured":"Scanlon CS, Van Tubergen EA, Inglehart RC, D\u2019Silva NJ. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res. 2013;92:114\u201321.","journal-title":"J Dent Res"},{"key":"2739_CR31","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1158\/1078-0432.CCR-08-0234","volume":"14","author":"MY Lee","year":"2008","unstructured":"Lee MY, Chou CY, Tang MJ, Shen MR. Epithelial-Mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and Snail up-regulation. Clin Cancer Res. 2008;14:4743\u201350.","journal-title":"Clin Cancer Res"},{"key":"2739_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070353","volume":"8","author":"GH Ha","year":"2013","unstructured":"Ha GH, Kim JL, Breuer EKY. TACC3 is essential for EGF-mediated EMT in cervical cancer. PLoS One. 2013;8, e70353.","journal-title":"PLoS One"},{"key":"2739_CR33","doi-asserted-by":"crossref","unstructured":"Sabbah M, Amami S, Redeuilh G, Julein S, Pr\u00e9vost G, Zimber A, Ouelaa R, Bracke M, De Wever O, Gespach C. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat. 2008;11:123\u201351.","DOI":"10.1016\/j.drup.2008.07.001"},{"key":"2739_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10544-014-9849-1","volume":"16","author":"TH Wu","year":"2014","unstructured":"Wu TH, Chiou YW, Chiu WT, Tang MJ, Chen CH, Yeh ML. The F-actin and adherence-dependent mechanical differentiation of normal epithelial cells after TGF-\u00df1-induced EMT (tEMT) using a microplatemeasurement system. Biomed Microdevices. 2014;16:465\u201378.","journal-title":"Biomed Microdevices"},{"key":"2739_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/path.1711760208","volume":"176","author":"CJ Vessey","year":"1995","unstructured":"Vessey CJ, Wilding J, Folarin N, Hirano S, Takeichi M, Soutter P, et al. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol. 1995;176:151\u20139.","journal-title":"J Pathol"},{"key":"2739_CR36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1158\/1541-7786.289.2.5","volume":"2","author":"N Reesink-Peters","year":"2004","unstructured":"Reesink-Peters N, Wisman GB, J\u00e9ronimo C, Tokumaru CY, Cohen Y, Dong SM, et al. Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol Cancer Res. 2004;2:289\u201395.","journal-title":"Mol Cancer Res"},{"key":"2739_CR37","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1158\/0008-5472.CAN-09-3289","volume":"70","author":"H Xiaoxia","year":"2010","unstructured":"Xiaoxia H, Schwarz JK, Lewis Jr JS, Huettner PC, Rader JS, Deasy JO, et al. A MicroRNA expression signature for cervical cancer prognosis. Cancer Res. 2010;70:1441\u20138.","journal-title":"Cancer Res"},{"key":"2739_CR38","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2147\/IJWH.S49471","volume":"5","author":"A Duenas-Gonzalez","year":"2014","unstructured":"Duenas-Gonzalez A, Serrano-Olvera A, Cetina L, Coronel J. New molecular targets against cervical cancer. Int J Women\u2019s Health. 2014;5:1023\u201331.","journal-title":"Int J Women\u2019s Health"},{"key":"2739_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A. Cancer Statictics, 2014. CA Cancer J Clin. 2014;64:9\u201329.","journal-title":"CA Cancer J Clin"},{"key":"2739_CR40","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/pros.21324","volume":"71","author":"M Greiner","year":"2011","unstructured":"Greiner M, Kreutzer B, Lang S, Jung V, Cavali\u00e9 A, Unteregger G, et al. Sec62 protein level is crucial for the ER stress tolerance of prostate cancer. Prostate. 2011;71:1074\u201383.","journal-title":"Prostate"},{"key":"2739_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.02.001","author":"TC Wright","year":"2015","unstructured":"Wright TC, Compagno J, Romano P, Grazioli V, Verma Y, Kershnar E, et al. Amplification of the 3q chromosomal region as a specific marker in cervical cancer. Am J Obstet Gynecol. 2015. doi: 10.1016\/j.ajog.2015.02.001 .","journal-title":"Am J Obstet Gynecol"},{"key":"2739_CR42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4149\/neo_2015_017","volume":"62","author":"P Kuglik","year":"2015","unstructured":"Kuglik P, Kasikova K, Smetana J, Vallova V, Lastuvkova A, Moukova L, et al. Molecular cytogenetic analyses of hTERC (3q26) and MYC (8q24) genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervical intraepithelial neoplasia and cervical carcinomas. Neoplasma. 2015;62:130\u20139.","journal-title":"Neoplasma"},{"key":"2739_CR43","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.1007\/s13277-014-1915-z","volume":"35","author":"X Wang","year":"2014","unstructured":"Wang X, Liu J, Xi H, Cai L. The significant diagnostic value of human telomerase RNA component (hTERC) gene detection in high-grade cervical lesions and invasive cancer. Tumour Biol. 2014;35:6893\u2013900.","journal-title":"Tumour Biol"},{"key":"2739_CR44","doi-asserted-by":"publisher","first-page":"8640","DOI":"10.1158\/0008-5472.CAN-04-4112","volume":"65","author":"H Kanao","year":"2005","unstructured":"Kanao H, Enomoto T, Kimura T, Fujita M, Nakashima R, Ueda Y, et al. Overexpression of LAMP3\/TSC403\/DC-LAMP promotes metastasis in uterine cervical cancer. Cancer Res. 2005;65:8640\u20135.","journal-title":"Cancer Res"},{"key":"2739_CR45","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1038\/sj.onc.1203597","volume":"19","author":"YY Ma","year":"2000","unstructured":"Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, Whang-Peng J, et al. PIK3CA as an oncogene in cervical cancer. Oncogene. 2000;19:2739\u201344.","journal-title":"Oncogene"},{"key":"2739_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053209","volume":"7","author":"J Oyanagi","year":"2012","unstructured":"Oyanagi J, Ogawa T, Sato H, Higashi S, Miyazaki K. Epithelial-mesenchymal transition stimulates human cancer cells to extend microtubule-based invasive protrusions and suppresses cell growth in collagen gel. PLoS One. 2012;7, e53209.","journal-title":"PLoS One"},{"key":"2739_CR47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.18388\/abp.2014_1841","volume":"61","author":"M Malicka-Blaszkiewicz","year":"2014","unstructured":"Malicka-Blaszkiewicz M, Filipczak N, Golab K, Juszczynska K, Sebzda T, Gburek J. Ovocystatin affects actin cytoskeleton organization and induces proapoptotic acivity. Acta Biochim Pol. 2014;61:753\u20138.","journal-title":"Acta Biochim Pol"},{"key":"2739_CR48","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/mp.2012.121","volume":"17","author":"WT Carpenter Jr","year":"2012","unstructured":"Carpenter Jr WT, Davis JM. Another view of the history of antipsychotic drug discovery and development. Mol Psychiatry. 2012;17:1168\u201373.","journal-title":"Mol Psychiatry"},{"key":"2739_CR49","doi-asserted-by":"publisher","first-page":"581.e1","DOI":"10.1016\/j.ajog.2009.12.016","volume":"202","author":"GR Jalali","year":"2010","unstructured":"Jalali GR, Herzog TJ, Dziura B, Walat R, Kilpatrick MW. Amplification of the chromosome 3q26 region shows high negative predictive value for nonmalignant transformation of LSIL cytologic finding. Am J Obstet Gynecol. 2010;202:581.e1\u20135.","journal-title":"Am J Obstet Gynecol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2739-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-016-2739-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2739-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2739-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:37:54Z","timestamp":1749559074000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2739-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,23]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2739"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2739-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,23]]},"article-number":"676"}}